$3.68
+0.14 (+3.95%)
Open$3.58
Previous Close$3.54
Day High$3.74
Day Low$3.55
52W High$54.03
52W Low$23.94
Volume—
Avg Volume557.0K
Market Cap216.84M
P/E Ratio58.47
EPS$0.64
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+1,162.0% upside
Current
$3.68
$3.68
Target
$46.44
$46.44
$29.94
$46.44 avg
$64.67
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 42.84M | 42.57M | 38.58M |
| Net Income | -111,494 | -129,666 | -108,514 |
| Profit Margin | -0.3% | -0.3% | -0.3% |
| EBITDA | -145,096 | -158,434 | -135,051 |
| Free Cash Flow | -87,273 | -114,389 | -110,539 |
| Rev Growth | -2.8% | +21.1% | -3.1% |
| Debt/Equity | 0.35 | 0.31 | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |